A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis

Published:2022-01 Issue:4 Volume:33 Page:
ISSN:2724-542X
Container-title:Minerva Biotechnology and Biomolecular Research
language:
Short-container-title:Minerva Biotechnol Biomol Res

Author:

CUSATO Jessica,CALCAGNO Andrea,ANTONUCCI Miriam,MARINARO Letizia,AVATANEO Valeria,DE NICOLÒ Amedeo,BONORA Stefano,DI PERRI Giovanni,D’AVOLIO Antonio

Publisher

Edizioni Minerva Medica

Subject

Molecular Biology,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://www.minervamedica.it/pdf.php?cod=R04Y2021N04A0204

Reference20 articles.

1. Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV‐1‐infected subjects with dyslipidaemia

2. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis

3. Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics

4. Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms

5. Epidemiological Approaches to Heart Disease: The Framingham Study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP